Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Camurus AB has 1 pending office action in Biotechnology & Pharmaceuticals. The record shows 1 distinct examiner and 1 distinct art unit, so the matter is managed through one examination assignment.
CONIGLIO, AUDREA JUNE BUCKLEY is the busiest examiner, with 1 pending matter. The response can be directed to that examiner, with claim support and technical distinctions developed for the applicable biotechnology and pharmaceutical context.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CONIGLIO, AUDREA JUNE BUCKLEY | 1 | 53.1% | +20.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18161828 | MIXTURES AND FORMULATIONS | CONIGLIO, AUDREA JUNE BUCKLEY | — |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18161828 | MIXTURES AND FORMULATIONS | CONIGLIO, AUDREA JUNE BUCKLEY | 1617 | §103DP | Non-Final OA | — | Pending | Jan 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCamurus AB has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Audrea June Buckley Coniglio has the most, with 1 of Camurus AB's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
